Marc Subirats

Marc Subirats has a diverse work experience in the healthcare and technology sectors. From 1999 to 2000, they worked in corporate strategy at Philips. In 2000, they founded and served as the CEO of Advance Medical, a global leader in telemedicine and virtual care services. In 2018, Advance Medical was acquired by Teladoc Health, where Marc became the General Manager of the International Business until 2019. Subsequently, they joined Nina Capital as a Limited Partner and Operating Partner from 2019 to 2020, and later became a Partner from 2021 to 2021. Marc also served as a Board Director at Methinks AI, a startup dedicated to applying machine learning and artificial intelligence in healthcare. Currently, they hold a position as a Board Director at Zetta Genomics Ltd, a company specializing in large-scale genomic data management for precision medicine.

Marc Subirats' education history begins in 1990 when they enrolled at the Universitat Autònoma de Barcelona. Marc pursued a Degree in Economics and completed their studies in 1995.

Later, in 1997, they attended the IESE Business School, where they pursued a Master of Business Administration (MBA) degree in Business and Economics. Marc completed this program in 1999.

During their time at IESE Business School, Marc also participated in an exchange program in 1998 at the China Europe International Business School (CEIBS), where they pursued an MBA degree as well. However, no specific field of study was mentioned for this program.